Ventyx Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Ventyx Biosciences

12/08/2024 22:02

* Ventyx Biosciences Inc  VTYX.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -91 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 58 cents per
share. Wall Street expected results to range from -69 cents
to -50 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Ventyx Biosciences Inc's reported EPS for the quarter was
a loss
of 45 cents​.
    * The company reported a quarterly loss of $31.95 million.
    * Ventyx Biosciences Inc shares had fallen by 10.4% this
quarter and lost 16.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $10.00 
This summary was machine generated from LSEG data August 12 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.58          -0.45          Beat
 Mar. 31 2024      -0.69          -0.62          Beat
 Dec. 31 2023      -0.90          -0.79          Beat
 Sep. 30 2023      -0.90          -0.92          Missed